Fiduciary Trust’s Barings Corporate Investors MCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-9,986
Closed -$207K 877
2025
Q3
$207K Hold
9,986
﹤0.01% 819
2025
Q2
$216K Hold
9,986
﹤0.01% 784
2025
Q1
$234K Hold
9,986
﹤0.01% 738
2024
Q4
$204K Buy
+9,986
New +$197K ﹤0.01% 659
2024
Q3
Sell
-10,000
Closed -$186K 664
2024
Q2
$186K Hold
10,000
﹤0.01% 608
2024
Q1
$172K Sell
10,000
-437
-4% -$7.98K ﹤0.01% 626
2023
Q4
$192K Hold
10,437
﹤0.01% 605
2023
Q3
$166K Hold
10,437
﹤0.01% 593
2023
Q2
$156K Hold
10,437
﹤0.01% 608
2023
Q1
$148K Hold
10,437
﹤0.01% 599
2022
Q4
$146K Hold
10,437
﹤0.01% 609
2022
Q3
$135K Hold
10,437
﹤0.01% 593
2022
Q2
$140K Hold
10,437
﹤0.01% 610
2022
Q1
$159K Buy
+10,437
New +$162K ﹤0.01% 646

Other funds holding MCI

Fiduciary Trust's MCI Position: Q4 2025 in Review

Fiduciary Trust sold out of Barings Corporate Investors (MCI) in Q4 2025, closing a stake of 9,986 shares — an estimated $207K sold.

Fiduciary Trust first reported a position in MCI in Q1 2022 and held it in 14 quarters. The position peaked at $234K in Q1 2025. 63 funds tracked by Wall St. Rank hold MCI as of Q4 2025.

  • Fiduciary Trust reported no remaining Barings Corporate Investors position as of Q4 2025 after selling out during the quarter.
  • Fiduciary Trust sold 9,986 Barings Corporate Investors shares in Q4 2025, an estimated $207K.
  • Fiduciary Trust first reported a position in Barings Corporate Investors in Q1 2022 and held it in 14 quarters.
  • Fiduciary Trust's Barings Corporate Investors position peaked at $234K in Q1 2025.
  • 63 funds tracked by Wall St. Rank held Barings Corporate Investors as of Q4 2025.

Based on Fiduciary Trust's 13F filing for Q4 2025, filed 13 Feb 2026.